Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study

(2018) David E Griffith et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease

(2016) Seong Mi Moon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobacterial Characteristics and Treatment Outcomes inMycobacterium abscessusLung Disease

(2016) Won-Jung Koh et al.   CLINICAL INFECTIOUS DISEASES

Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology

(2016) M. Jankovic et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Standardized interpretation of antibiotic susceptibility testing and resistance genotyping forMycobacterium abscessuswith regard to subspecies anderm41sequevar

(2016) Faiza Mougari et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intermittent Antibiotic Therapy for Nodular BronchiectaticMycobacterium aviumComplex Lung Disease

(2015) Byeong-Ho Jeong et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination

(2015) M.-R. Lee et al.   CLINICAL MICROBIOLOGY AND INFECTION

Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease

(2014) Richard J. Wallace et al.   CHEST

Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance

(2013) Jakko van Ingen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength

(2013) Jeffrey C. Andrews et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens

(2012) Won-Jung Koh et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?

(2011) Jakko van Ingen et al.   INFECTION GENETICS AND EVOLUTION

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clinical Significance of Differentiation ofMycobacterium massiliensefromMycobacterium abscessus

(2010) Won-Jung Koh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Assessment of Clarithromycin Susceptibility in Strains Belonging to theMycobacterium abscessusGroup byerm(41) andrrlSequencing

(2010) Sylvaine Bastian et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic Treatment ofMycobacterium abscessusLung Disease

(2009) Kyeongman Jeon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease

(2009) M. Santin et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands

(2009) J van Ingen et al.   THORAX

Anatomic Lung Resection for Nontuberculous Mycobacterial Disease

(2008) John D. Mitchell et al.   ANNALS OF THORACIC SURGERY

Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France

(2008) C Andrejak et al.   THORAX